These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 24440063)
1. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. Weisbrod AB; Kitano M; Thomas F; Williams D; Gulati N; Gesuwan K; Liu Y; Venzon D; Turkbey I; Choyke P; Yao J; Libutti SK; Nilubol N; Linehan WM; Kebebew E J Am Coll Surg; 2014 Feb; 218(2):163-9. PubMed ID: 24440063 [TBL] [Abstract][Full Text] [Related]
2. [Gastroenterological manifestations of von Hippel-Lindau disease - a case report]. Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T Pol Merkur Lekarski; 2017 Aug; 43(254):66-68. PubMed ID: 28875972 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520 [TBL] [Abstract][Full Text] [Related]
4. Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome. Weisbrod AB; Liewehr DJ; Steinberg SM; Patterson EE; Libutti SK; Linehan WM; Nilubol N; Kebebew E Ann Surg Oncol; 2012 Jun; 19(6):2054-9. PubMed ID: 22350603 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Kitano M; Millo C; Rahbari R; Herscovitch P; Gesuwan K; Webb RC; Venkatesan AM; Phan GQ; Hughes MS; Libutti SK; Nilubol N; Linehan WM; Kebebew E Surgery; 2011 Dec; 150(6):1122-8. PubMed ID: 22136831 [TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. Marcos HB; Libutti SK; Alexander HR; Lubensky IA; Bartlett DL; Walther MM; Linehan WM; Glenn GM; Choyke PL Radiology; 2002 Dec; 225(3):751-8. PubMed ID: 12461257 [TBL] [Abstract][Full Text] [Related]
7. Two Childhood Pheochromocytoma Cases due to von Hippel-Lindau Disease, One Associated with Pancreatic Neuroendocrine Tumor: A Very Rare Manifestation. Dağdeviren Çakır A; Turan H; Aykut A; Durmaz A; Ercan O; Evliyaoğlu O J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):179-182. PubMed ID: 29022557 [TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions. Sadowski SM; Weisbrod AB; Ellis R; Patel D; Alimchandani M; Quezado M; Millo C; Venzon DJ; Nilubol N; Linehan WM; Kebebew E J Am Coll Surg; 2014 May; 218(5):997-1003. PubMed ID: 24661849 [TBL] [Abstract][Full Text] [Related]
9. Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678 [TBL] [Abstract][Full Text] [Related]
10. Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease. Keutgen XM; Hammel P; Choyke PL; Libutti SK; Jonasch E; Kebebew E Nat Rev Clin Oncol; 2016 Sep; 13(9):537-49. PubMed ID: 27030075 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Libutti SK; Choyke PL; Bartlett DL; Vargas H; Walther M; Lubensky I; Glenn G; Linehan WM; Alexander HR Surgery; 1998 Dec; 124(6):1153-9. PubMed ID: 9854597 [TBL] [Abstract][Full Text] [Related]
12. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place. de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468 [TBL] [Abstract][Full Text] [Related]
13. Potential value of EUS in pancreatic surveillance of VHL patients. van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551 [TBL] [Abstract][Full Text] [Related]
15. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. von Dücker L; Walz MK; Voss C; Arnold G; Eng C; Neumann HP World J Surg; 2011 Mar; 35(3):563-7. PubMed ID: 21181474 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome]. Liu WK; Tian XD; Yang YM Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308 [TBL] [Abstract][Full Text] [Related]
17. Endocrine manifestations of von Hippel-Lindau disease. Cassol C; Mete O Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110 [TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. Libutti SK; Choyke PL; Alexander HR; Glenn G; Bartlett DL; Zbar B; Lubensky I; McKee SA; Maher ER; Linehan WM; Walther MM Surgery; 2000 Dec; 128(6):1022-7;discussion 1027-8. PubMed ID: 11114638 [TBL] [Abstract][Full Text] [Related]
19. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center. Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111 [TBL] [Abstract][Full Text] [Related]